SCHEMBL20111359

SCHEMBL20111359

CC1CCC(C2CCC(COc3ccc4c(c3F)-c3c-4cc(O)c(F)c3F)CO2)CC1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
SCN9A Q15858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20111716 0.88 SCN9A (0.36) HTR2AHTR2CSCN9A
SCHEMBL20111311 0.86 HTR2A (0.34) HTR2AHTR2C
SCHEMBL20111471 0.79
SCHEMBL20102590 0.79
SCHEMBL15445746 0.78 ALDH1A1 (0.33) HTR2AHTR2CSCN9A
SCHEMBL20117747 0.78 HPGD (0.36) HTR2AHTR2CSCN9A
SCHEMBL20111361 0.77 HPGD (0.36) HTR2AHTR2CSCN9A
SCHEMBL20111269 0.76 HTR2A (0.33) HTR2AHTR2C
SCHEMBL15445743 0.76 HPGD (0.32)
SCHEMBL20117670 0.75 GRM2 (0.33) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2019-06-18 US disclosed
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE YBX1, PIEZO1, C1S HTR2A 791/4885HTR2C 134/4885SCN9A 2846/4885
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device YBX1, PIEZO1, C1S HTR2A 791/4885HTR2C 134/4885SCN9A 2846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.